-+ 0.00%
-+ 0.00%
-+ 0.00%
CTT Pharmaceutical adds Karen Larson to board as independent director
Share
Listen to the news
CTT Pharmaceutical adds Karen Larson to board as independent director
  • CTT Pharmaceutical Holdings named Karen Larson as an independent board member.
  • Larson is a Certified Financial Planner. She founded an analytical reporting business later sold to Morningstar.
  • She previously served as a senior vice president, investment banker at Chase Manhattan Bank.
  • Since 2017, Larson has been founder of Broad Avenue Studios, a commercial and residential real estate company.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CTT Pharmaceutical Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-005750), on September 23, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending